3203

Novel and highly Specific Anti-Cancer Peptide Drug derived from NAF-1

Nechushtai Rachel, HUJI, Faculty of Science, The Alexander Silberman Institute for Life Sciences
FRIEDLER Assaf, HUJI, Faculty of Science, The Institute of Chemistry
Additional information will be provided upon request

Contact for more information:

Ariela Markel
VP, Business Development, Healthcare
+972-2-6586608